193 related articles for article (PubMed ID: 31794800)
1. Chemical induced inflammation of the liver breaks tolerance and results in autoimmune hepatitis in Balb/c mice.
Chi G; Pei JH; Ma QY; Ru YX; Feng ZH
Immunol Lett; 2020 Feb; 218():44-50. PubMed ID: 31794800
[TBL] [Abstract][Full Text] [Related]
2. The influence of genetic predisposition and autoimmune hepatitis inducing antigens in disease development.
Hardtke-Wolenski M; Dywicki J; Fischer K; Hapke M; Sievers M; Schlue J; Anderson MS; Taubert R; Noyan F; Manns MP; Jaeckel E
J Autoimmun; 2017 Mar; 78():39-45. PubMed ID: 27974250
[TBL] [Abstract][Full Text] [Related]
3. Cytochrome P450 2D6 as a model antigen.
Christen U; Holdener M; Hintermann E
Dig Dis; 2010; 28(1):80-5. PubMed ID: 20460894
[TBL] [Abstract][Full Text] [Related]
4. Molecular mimicry rather than identity breaks T-cell tolerance in the CYP2D6 mouse model for human autoimmune hepatitis.
Ehser J; Holdener M; Christen S; Bayer M; Pfeilschifter JM; Hintermann E; Bogdanos D; Christen U
J Autoimmun; 2013 May; 42():39-49. PubMed ID: 23200317
[TBL] [Abstract][Full Text] [Related]
5. The induction of autoimmune hepatitis in the human leucocyte antigen-DR4 non-obese diabetic mice autoimmune hepatitis mouse model.
Yuksel M; Xiao X; Tai N; Vijay M; Gülden E; Beland K; Lapierre P; Alvarez F; Hu Z; Colle I; Ma Y; Wen L
Clin Exp Immunol; 2016 Nov; 186(2):164-176. PubMed ID: 27414259
[TBL] [Abstract][Full Text] [Related]
6. Effects and regulation of autoreactive CD8+ T cells in a transgenic mouse model of autoimmune hepatitis.
Zierden M; Kühnen E; Odenthal M; Dienes HP
Gastroenterology; 2010 Sep; 139(3):975-86, 986.e1-3. PubMed ID: 20639127
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of autoimmune hepatic fibrogenesis induced by an adenovirus encoding the human liver autoantigen cytochrome P450 2D6.
Hintermann E; Ehser J; Bayer M; Pfeilschifter JM; Christen U
J Autoimmun; 2013 Aug; 44():49-60. PubMed ID: 23809878
[TBL] [Abstract][Full Text] [Related]
8. Aetiopathogenesis of autoimmune hepatitis.
Vergani D; Mieli-Vergani G
World J Gastroenterol; 2008 Jun; 14(21):3306-12. PubMed ID: 18528928
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Concanavalin a-Induced Murine Autoimmune Hepatitis Models.
Ye T; Wang T; Yang X; Fan X; Wen M; Shen Y; Xi X; Men R; Yang L
Cell Physiol Biochem; 2018; 46(3):1241-1251. PubMed ID: 29672295
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis resulting from liver-specific expression and recognition of self-antigen.
Buxbaum J; Qian P; Allen PM; Peters MG
J Autoimmun; 2008 Nov; 31(3):208-15. PubMed ID: 18513923
[TBL] [Abstract][Full Text] [Related]
11. Non-alcoholic fatty liver disease (NAFLD) potentiates autoimmune hepatitis in the CYP2D6 mouse model.
Müller P; Messmer M; Bayer M; Pfeilschifter JM; Hintermann E; Christen U
J Autoimmun; 2016 May; 69():51-8. PubMed ID: 26924542
[TBL] [Abstract][Full Text] [Related]
12. Regulatory T cells in autoimmune hepatitis: an updated overview.
Longhi MS; Mieli-Vergani G; Vergani D
J Autoimmun; 2021 May; 119():102619. PubMed ID: 33652348
[TBL] [Abstract][Full Text] [Related]
13. TLR2/4 ligand-amplified liver inflammation promotes initiation of autoimmune hepatitis due to sustained IL-6/IL-12/IL-4/IL-25 expression.
Chi G; Feng XX; Ru YX; Xiong T; Gao Y; Wang H; Luo ZL; Mo R; Guo F; He YP; Zhang GM; Tian DA; Feng ZH
Mol Immunol; 2018 Jul; 99():171-181. PubMed ID: 29793131
[TBL] [Abstract][Full Text] [Related]
14. Aetiopathogenesis of autoimmune hepatitis.
Longhi MS; Ma Y; Mieli-Vergani G; Vergani D
J Autoimmun; 2010 Feb; 34(1):7-14. PubMed ID: 19766456
[TBL] [Abstract][Full Text] [Related]
15. TNF-Producing Th1 Cells Are Selectively Expanded in Liver Infiltrates of Patients with Autoimmune Hepatitis.
Bovensiepen CS; Schakat M; Sebode M; Zenouzi R; Hartl J; Peiseler M; Li J; Henze L; Woestemeier A; Schramm C; Lohse AW; Herkel J; Weiler-Normann C
J Immunol; 2019 Dec; 203(12):3148-3156. PubMed ID: 31685647
[TBL] [Abstract][Full Text] [Related]
16. Hepatic T Cell Tolerance Induction in An Inflammatory Environment.
Dywicki J; Noyan F; Misslitz AC; Hapke M; Galla M; Schlue J; Liblau RS; Taubert R; Manns MP; Jaeckel E; Hardtke-Wolenski M
Dig Dis; 2018; 36(2):156-166. PubMed ID: 29020680
[TBL] [Abstract][Full Text] [Related]
17. Soluble Fgl2 restricts autoimmune hepatitis progression via suppressing Tc17 and conventional CD8+ T cell function.
Ai G; Yan W; Yu H; Xiao F; Xi D; Ma K; Huang J; Luo X; Wan X; Ning Q
J Gene Med; 2018 Jul; 20(7-8):e3023. PubMed ID: 29756667
[TBL] [Abstract][Full Text] [Related]
18. Autoantigen-specific regulatory T cells, a potential tool for immune-tolerance reconstitution in type-2 autoimmune hepatitis.
Longhi MS; Hussain MJ; Kwok WW; Mieli-Vergani G; Ma Y; Vergani D
Hepatology; 2011 Feb; 53(2):536-47. PubMed ID: 21274874
[TBL] [Abstract][Full Text] [Related]
19. Impact of Antigen Presentation Mechanisms on Immune Response in Autoimmune Hepatitis.
Fasano R; Malerba E; Prete M; Solimando AG; Buonavoglia A; Silvestris N; Leone P; Racanelli V
Front Immunol; 2021; 12():814155. PubMed ID: 35116039
[TBL] [Abstract][Full Text] [Related]
20. Adaptive immunity in autoimmune hepatitis.
Longhi MS; Ma Y; Mieli-Vergani G; Vergani D
Dig Dis; 2010; 28(1):63-9. PubMed ID: 20460892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]